20 Mar 2024
18:29 CET |
ONWARD MEDICAL |
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Public Offering in France for an Indicative Amount of EUR 15 Million, with an Up to EUR 5 Million Upsize Option
|
20101025 Health Services |
- |
20 Mar 2024
18:24 CET |
ONWARD MEDICAL |
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Public Offering in France for an Indicative Amount of EUR 15 Million, with an Up to EUR 5 Million Upsize Option
|
20101025 Health Services |
- |
20 Mar 2024
18:24 CET |
ONWARD MEDICAL |
ONWARD® Medical Lance une Augmentation de Capital par le Biais d'une Procédure de Construction Accélérée d'un Livre d'Ordres et le Biais d'une Offre au Public en France d'un Montant Indicatif de 15 millions d'euros avec l’Option de Lever j
|
20101025 Health Services |
- |
20 Mar 2024
18:00 CET |
BIOTALYS NV |
Invitation to the ordinary general shareholders meeting and an extraordinary shareholders meeting
|
55201015 Fertilizers |
- |
20 Mar 2024
08:30 CET |
SOLVAY |
Participatiemelding van DME Advisors and DME Capital Management
|
55201000 Chemicals: Diversified |
Corporate life |
20 Mar 2024
08:30 CET |
SOLVAY |
Participation notification by DME Advisors and DME Capital Management
|
55201000 Chemicals: Diversified |
Corporate life |
20 Mar 2024
08:30 CET |
SOLVAY |
Notification de participation par DME Advisors and DME Capital Management
|
55201000 Chemicals: Diversified |
Corporate life |
20 Mar 2024
07:00 CET |
BIOSENIC |
BioSenic présente des données précliniques concluantes sur son médicament ATO pour le contrôle des principaux symptômes au Congrès mondial 2024 sur la sclérose systémique
|
20103010 Biotechnology |
Corporate life |
20 Mar 2024
07:00 CET |
BIOSENIC |
BioSenic presents successful preclinical data on its ATO medication for controlling key symptoms at the 2024 Systemic Sclerosis World Congress
|
20103010 Biotechnology |
Corporate life |
19 Mar 2024
21:05 CET |
NYXOAH SA |
Nyxoah Annonce que l'Étude Pivot DREAM U.S. Atteint les Critères d'Évaluation Primaires
|
20102010 Medical Equipment |
Other subject |
19 Mar 2024
21:05 CET |
NYXOAH SA |
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
|
20102010 Medical Equipment |
Other subject |
19 Mar 2024
18:30 CET |
ABO GROUP ENVIRONMENT |
Uitbetaling kapitaalvermindering
|
50101015 Engineering and Contracting Services |
New |
19 Mar 2024
18:30 CET |
ABO GROUP ENVIRONMENT |
Capital reduction payout
|
50101015 Engineering and Contracting Services |
New |
19 Mar 2024
18:30 CET |
ABO GROUP ENVIRONMENT |
Paiement de la réduction du capital
|
50101015 Engineering and Contracting Services |
New |
19 Mar 2024
18:00 CET |
FAGRON |
Openbaarmaking kennisgeving van Mawer Investment Management Ltd.
|
20102010 Medical Equipment |
Other subject |
19 Mar 2024
18:00 CET |
FAGRON |
Disclosure notification from Mawer Investment Management Ltd.
|
20102010 Medical Equipment |
Other subject |
19 Mar 2024
08:31 CET |
TITAN CEMENT |
Programme de rachats d'actions
|
50101030 Cement |
Other subject |
19 Mar 2024
08:31 CET |
TITAN CEMENT |
Share buyback programme
|
50101030 Cement |
Other subject |
19 Mar 2024
08:30 CET |
CIE BOIS SAUVAGE |
Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 11/03/2024 tot 15/03/2024
|
30202010 Asset Managers and Custodians |
Other subject |
19 Mar 2024
08:30 CET |
CIE BOIS SAUVAGE |
Cie du Bois Sauvage: Buy back of own shares – week from 11/03/2024 to 15/03/2024
|
30202010 Asset Managers and Custodians |
Other subject |
19 Mar 2024
08:30 CET |
CIE BOIS SAUVAGE |
Cie du Bois Sauvage : Rachat d’actions propres – semaine du 11/03/2024 au 15/03/2024.
|
30202010 Asset Managers and Custodians |
Other subject |
19 Mar 2024
08:00 CET |
KBC |
KBC Group: Update regarding the KBC Group share buyback programme
|
30101010 Banks |
Other financial transaction |
19 Mar 2024
08:00 CET |
KBC |
KBC Groupe: Mise à jour concernant le programme de rachat d’actions propres de KBC Groupe
|
30101010 Banks |
Other financial transaction |
19 Mar 2024
08:00 CET |
KBC |
KBC Groep: Update m.b.t. inkoopprogramma van KBC Groep voor eigen aandelen
|
30101010 Banks |
Other financial transaction |
19 Mar 2024
07:00 CET |
ION BEAM APPLICATIONS |
IBA signs contract to install a Be-Efficient irradiation solution in Germany
|
20102010 Medical Equipment |
News contracts |
19 Mar 2024
07:00 CET |
ION BEAM APPLICATIONS |
IBA signe un contrat pour l'installation d'une solution d'irradiation Be-Efficient en Allemagne
|
20102010 Medical Equipment |
News contracts |
18 Mar 2024
21:22 CET |
EURONAV |
Resultaten van het verplicht openbaar overnamebod op Euronav NV uitgebracht door CMB NV
|
50206030 Marine Transportation |
Other subject |
18 Mar 2024
21:21 CET |
EURONAV |
Results of the mandatory public takeover bid on Euronav NV launched by CMB NV
|
50206030 Marine Transportation |
Other subject |
18 Mar 2024
18:00 CET |
AZELIS GROUP NV |
Azelis LTIP Share Buyback Program 2024 – Update
|
55201000 Chemicals: Diversified |
Other subject |
18 Mar 2024
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
18 Mar 2024
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
18 Mar 2024
18:00 CET |
VAN DE VELDE |
VAN DE VELDE : inkoop eigen aandelen
|
40204020 Clothing and Accessories |
Other subject |
18 Mar 2024
18:00 CET |
AZELIS GROUP NV |
Azelis LTIP Aandeleninkoopprogramma 2024 - update
|
55201000 Chemicals: Diversified |
Other subject |
18 Mar 2024
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
18 Mar 2024
18:00 CET |
VAN DE VELDE |
VAN DE VELDE : acquisition of treasury shares
|
40204020 Clothing and Accessories |
Other subject |
18 Mar 2024
17:46 CET |
LOTUS BAKERIES |
Disposal of treasury shares
|
45102020 Food Products |
Other subject |
18 Mar 2024
08:00 CET |
CAMPINE |
Campine 2.0 zet nieuwe records neer
|
55201020 Specialty Chemicals |
New |
18 Mar 2024
08:00 CET |
CAMPINE |
Records in 2023 @ Campine 2.0
|
55201020 Specialty Chemicals |
New |
18 Mar 2024
08:00 CET |
CAMPINE |
Campine 2.0 bat tous les records
|
55201020 Specialty Chemicals |
New |
18 Mar 2024
07:44 CET |
CRESCENT |
OCCASIONEEL PERSBERICHT - Publiek-private samenwerking gemeente Aerodrom en Crescent Smart City
|
15101010 Telecommunications Equipment |
Other subject |
18 Mar 2024
07:40 CET |
CRESCENT |
OCCASIONAL PRESS RELEASE - Public-Private partnership municipality Aerodrom and Crescent Smart City
|
15101010 Telecommunications Equipment |
Other subject |
18 Mar 2024
07:30 CET |
ONWARD MEDICAL |
ONWARD® Medical Successfully Completes Benchmark Testing on Path to Commercialize ARC-EX® System
|
20101025 Health Services |
- |
18 Mar 2024
07:22 CET |
JENSEN-GROUP |
Inkoop eigen aandelen - wekelijkse update
|
50204000 Machinery: Industrial |
Other subject |
18 Mar 2024
07:21 CET |
JENSEN-GROUP |
Share buyback – weekly update
|
50204000 Machinery: Industrial |
Other subject |
18 Mar 2024
07:00 CET |
BIOTALYS NV |
Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG
|
55201015 Fertilizers |
- |
15 Mar 2024
18:30 CET |
UMICORE |
Umicore - Déclarations de transparence par BlackRock, Inc.
|
55201020 Specialty Chemicals |
New |
15 Mar 2024
18:30 CET |
UMICORE |
Umicore - Transparantieverklaringen van BlackRock, Inc.
|
55201020 Specialty Chemicals |
New |
15 Mar 2024
18:30 CET |
UMICORE |
Umicore - Transparency notifications by BlackRock, Inc.
|
55201020 Specialty Chemicals |
New |
15 Mar 2024
17:45 CET |
WAREHOUSES ESTATES BELGIUM - W.E.B. |
WEB SA - JAARRESULTATEN BOEKJAAR 2023
|
35102030 Office REITs |
Other subject |
15 Mar 2024
17:45 CET |
WAREHOUSES ESTATES BELGIUM - W.E.B. |
WEB SA - RESULTATS ANNUELS EXERCICE 2023
|
35102030 Office REITs |
Other subject |